Spectrum of hypertensive emergencies in pregnancy

Critical Care Clinics

Volumn 20, Issue 4, 2004, Pages 697-712

  Henry, Charles S ^a   Biedermann, Scott A ^a   Campbell, Michel F ^a   Guntupalli, Jayarama S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; HYDRALAZINE; LABETALOL; METHYLDOPA;

BRADYCARDIA; CLINICAL TRIAL; DISEASE COURSE; ECLAMPSIA; HELLP SYNDROME; HUMAN; HYPOGLYCEMIA; HYPOTENSION; MATERNAL HYPERTENSION; PATHOGENESIS; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; ECLAMPSIA; FEMALE; HELLP SYNDROME; HUMANS; HYPERTENSION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; SEIZURES;

EID: 4544360379     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2004.05.014     Document Type: Review

References (84)

1. P. August, and M.D. Lindheimer Pathophysiology of preeclampsia Hypertension 142 1995 2407 2426
2. E. Dafnis, and S. Sabatini The effect of pregnancy on renal function: physiology and pathophysiology Am J Med Sci 303 1992 184 205
3. B.M. Sibai Chronic hypertension in pregnancy Obstet Gynecol 100 2002 369 377
4. B.J. Wilson, M.S. Watson, G.J. Prescott, S. Sunderland, D.M. Campbell, and P. Hannaford Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study BMJ 326 2003 1 7
5. C.A. Winkel, L. Milewich, C.R. Parker, N.F. Grant, E.R. Simpson, and P.C. MacDonald Conversion of plasma progesterone to desoxycorticosterone in men, nonpregnant and pregnant women and adrenalectomized subjects J Clin Invest 66 1980 803 812
6. L.D. Longo, and J.S. Hardesty Maternal blood volume: measurement, hypothesis of control, and clinical considerations Rev Perinatal Med. 5 1984 35 43
7. S.C. Robson, S. Hunter, R.J. Boys, and W. Dunlop Serial study of factors influencing changes in cardiac output during human pregnancy Am J Physiol 256 1989 H1060 H1065
8. C.W.G. Redman Hypertension in pregnancy J.D. Swales Textbook of hypertension 1994 Blackwell Science London 767 784
9. R.L. Ferrer, B.M. Sibai, C.D. Murlow, E. Chiquette, K.R. Stevens, and J. Cornell Management of mild chronic hypertension during pregnancy: a review Obstet Gynecol 96 2000 849 860
10. J.C. Keith Jr, C.D. Thatcher, and R.G. Schaub Beneficial effects of U-63, 557A, a thromboxane synthetase inhibitor, in an ovine model of pregnancy-induced hypertension Am J Obstet Gynecol 157 1987 199 203
11. S. Bachmann, and P. Mundel NO in the kidney: synthesis, localization and function Am J Kidney Dis 24 1994 112 129
12. S.P. Seligman, J.P. Buyon, R.M. Clancy, B.K. Young, and S.B. Abramson The role of nitric oxide in the pathogenesis of preeclamsia Am J Obstet Gynecol 171 1994 944 948
13. J.P. Granger, and B.T. Alexander Abnormal pressure natriuresis in hypertension: role of nitric oxide Acta Physiol Scand 168 2000 161 168
14. S.L. Opsjon, R. Austgulen, and A. Waage Interlukin-1, interlukin-6 and tumor necrosis factor at delivery in preeclamptic disorders Acta Obstet Gynecol Scand 74 1995 19 26
15. B.A. Clark, L. Halvorson, B. Sachs, and F.H. Epstein Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment Am J Obstet Gynecol 166 1992 962 968
16. Y. Takeda-Matsubara, K. Matsubara, H. Ochi, I. Masaharu, M. Iwai, and M. Horiuchi Expression of endothelial angiotensin II receptor mRNA in pregnancy-induced hypertension Am J Hypertens 16 2003 993 999
17. G.S. Vince, P.M. Starkey, R. Austgulen, D. Kwiatkowski, and C.W.G. Redman Interlukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia Br J Obstet Gynaecol 102 1995 20 25
18. K.G. Zafirovska, V.T. Maleska, S.V. Bogdanovska, L.A. Lozance, M. Masin-Paneva, and B.D. Gerasimovska Plasma atrial natriuretic peptide, endothelin-1, aldosterone and plasma-renin activity in pregnancy-induced hypertension J Hypertens 17 1999 1317 1322
19. N.F. Gant, G.L. Daley, S. Chand, P.J. Whalley, and P.C. McDonald A study of angiotensin II pressor response throughout primigravid pregnancy J Clin Invest 52 1973 2682 2689
20. B.S. Horstkamp, H. Kiess, J. Kramer, H. Riess, W. Henrich, and J.W. Dudenhausen Activated protein C resistance shows an association with pregnancy-induced hypertension Hum Reprod 14 1999 3112 3115
21. P.M. Catalano, E.D. Tyzbir, R.R. Wolfe, J. Calles, N.M. Roman, and S.B. Amini Carbohydrate metabolism during pregnancy in control subjects and in women with gestational diabetes Am J Physiol 264 1993 E60 E67
22. C.L. Bryson, G.N. Ioannou, S.J. Rulyak, and C. Critchlow Association between gestational diabetes and pregnancy-induced hypertension Am J Epidemiol 158 2003 1148 1153
23. S.L. Kjos, and T.A. Buchanan Gestational diabetes N Engl J Med 341 1999 1749 1756
24. C.G. Solomon, W.C. Willett, V.J. Carey, J. Rich-Edwards, D.J. Hunter, and G.A. Colditz A prospective study of pregravid determinants of gestational diabetes mellitus JAMA 278 1997 1078 1083
25. L.D. Ritchie, and J.C. King Dietary calcium and pregnancy induced hypertension: is there a relation? Am J Clin Nutr 71 suppl 2000 1371 1374
26. Report of the national high blood pressure education program: Working Group Report on High Blood Pressure in Pregnancy Am J Obstet Gynecol 183 2000 S1 S22
27. B.M. Sibai, and G.D. Anderson Pregnancy outcome of intensive therapy in severe hypertension in first trimester of pregnancy Obstet Gynecol 67 1986 517 522
28. E. Rey, and A. Couturier The prognosis of pregnancy in women with chronic hypertension Am J Obstet Gynecol 171 1994 410 416
29. L. Jain Effect of pregnancy-induced and chronic hypertension on pregnancy outcome J Perinatol 17 1997 425 427
30. N.W. Svenningsen, H. Liedholm, and A. Aberg Hypertension in pregnancy and the infant: a controlled follow-up study Acta Obstet Gynecol Scand Suppl 118 1984 103 106
31. B.M. Sibai, M. Lindheimer, J. Hauth, S. Caritis, P. Van-Dorsten, and M. Klebanoff Risk factors for preeclampsia, abruption placentae, and adverse neonatal outcomes among women with chronic hypertension N Engl J Med 339 1998 667 671
32. E. Keely Endocrine causes of hypertension in pregnancy: when to start looking for Zebras Semin Pernatal 22 1998 471
33. R.D. Safian, and S.C. Texter Renal-artery stenosis N Engl J Med 344 2001 431
34. P.F. Plouin, G. Breart, F. Maillard, E. Papiernik, and J.P. Relier Comparison of the antihypertensive efficacy and prenatal safety of Labatolol and methyldopa in the treatment of hypertension in pregnancy: a randomized control trial Br J Obstet Gyneacol 95 1988 868 876
35. B.M. Sibai Diagnosis and management of gestational hypertension and preeclampsia Obstet Gynecol 102 2003 181 192
36. W.C. Mabie, A.R. Gonzaler, B.M. Sibai, and E. Amon A comparative trial of labetolol and hydralazine in the acute management of severe hypertension complicating pregnancy Obstet Gynecol 70 1987 328 333
37. G.J. Vink, J. Moodley, and R.H. Philpott Effect of hydralazine on the fetus in the treatment of maternal hypertension Obstet Gynecol 55 1980 519 522
38. L.A. Magee, E. Elran, S.B. Bull, A. Logan, and G Koren Risks and benefits of β receptor blockers for pregnancy hypertension: overview of the randomized trials Eu J Obstet Gynecol Reprod Biol 88 2000 15 26
39. E. Paren, G. Holzberg, E. Zmora, and V. Insler β Adrenargic blocking agents in the treatment of pregnancy-induced hypertension Int J Clin Pharmacol Ther 33 1995 519 522
40. M.G. Marlettini, S. Crippa, A.M. Morselli-Lobote, A. Contrarini, and C. Orlandi Randomized comparison of calcium antagonists and beta-blockers in the treatment of pregnancy induced hypertension Curr Ther Res 48 1995 684 689
41. D. Janet, B. Carbonne, E. Sebban, and J. Millez Nicardopine vs metaprolol in the treatment of hypertension during pregnancy: a randomized comparitive trial Obstet Genecol 84 1994 354 359
42. P.G. Pryde, A.B. Sedman, C.E. Nugent, and M. Barr Jr Angiotensin converting enzyme inhibitor fetopathy J Am Soc Nephrol 3 1993 1575 1582
43. A. Shotan, J. Widerhorn, A. Hurst, and U. Elkayam Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use Am J Med 96 1994 451 456
44. L.A. Magee, M.P. Ornstein, and P. von Dalelszen Fortnightly review: management of hypertension in pregnancy BMJ 318 1999 1322 1336
45. 2-receptor blockers Eu J Obstet Gynecol Reprod Biol 95 2001 22 36
46. C.M. Middlekoop, G.A. Dekker, A.A. Kraayenbrink, and C. Popp-Snijders Platelet poor plasma serotonin in normal and preeclamptic pregnancy Clin Chem 39 2001 1675 1678
47. R.L. Ferrer, B.M. Sibai, C.D. Murlow, E. Chiquette, K.R. Stevens, and J. Cornell Management of mild chronic hypertension during pregnancy: a review Obstet Gynecol 96 2000 849 860
48. K.Y. Lain, and J.M. Roberts Contemporary concepts of the pathogenesis and management of preeclampsia JAMA 287 2001 3183
49. J.W. Meekins, R. Pijnenborg, M. Hanssens, I.R. McFodjen, and A. Van Asshe A study of placental bed spiral arteries and trophoblast invasion in normal and pre-eclamptic pregnancies Br J Obstet Gynecol 101 1994 669 674
50. J.C. Cross, Z. Werb, and S.J. Fisher Implantation of the placenta: key pieces of the development puzzle Science 266 1994 1508
51. Y. Zhou, C.H. Damsky, and S.J. Fisher Preeclampsia is associated with failure of human trophoblast to mimic a vascular adhesion phenotype: one cause of defective endovascular invasion in this syndrome J Clin Invest 99 1997 2152 2164
52. R. Arngrimsson, T.R. Sigurard, M.L. Frigge, R.I. Bjornad, T. Jonsson, and H. Stefansson A genome-wide scan reveals a maternal susceptibility locus for preeclampsia on chromosome 2p13 Hum Mol Genet 8 1999 1799
53. E.K. Moses, J.A. Lade, G. Guo, A.N. Wilton, M. Grehan, and K. Freed A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for preeclampsia on chromosome 2 Am J Human Genet 67 2000 1581 1585
54. A.M. Lachmeijer, R. Arngrimsson, E.J. Bastiaans, M.L. Frigge, G. Pals, and S. Sigurdardottir A genome-wide scan for preeclampsia in the Netherlands Eur J Hum Genet 9 2001 758 764
55. S.E. Maynard, J.Y. Min, J. Marchan, K.H. Lin, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
56. B.M. Sibai, T. Gordon, E. Thom, S.N. Curtis, M. Klebanoff, and D. McNellis Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institutes of Child Health and Human Development Network of Maternal and Fetal Medicine Units Am J Obstet Gynecol 172 1995 642 648
57. B.M. Sibai, R.J. Ewell, R.J. Levine, M. Klebanoff, J. Esterlitz, and P.M. Catalano Risk factors associated with preeclampsia and eclampsia in healthy nulliparous women Am J Obstet Gynecol 177 1997 1003 1010
58. J. Zhang, A.K. Mark, R.J. Levine, M. Puri, and P. Moyer The puzzling association between smoking and hypertension during pregnancy Am J Obstet Gynecol 181 1999 1407 1413
59. J.L. England, R.J. Levine, C. Qian, C.D. Morris, B.M. Sibai, and P.M. Catalano Smoking before pregnancy and risk of gestational hypertension and preeclampsia Am J Obstet Gynecol 186 2002 1035 1040
60. C.V. Ananth, W.A. Bowes, D.A. Savitz, and E.R. Luther Relationship between pregnancy induced hypertension and placenta previa: a population based study Am J Obstet Gynecol 177 1997 997 1002
61. E.W. Page, and R. Christenson Influence of blood pressure changes with and without proteinuria upon outcome of pregnancy Am J Obstet Gynecol 166 1976 821 833
62. S. Ferrazanni, A. Caruso, S. De Carolis, I.V. Martino, and S. Mancuso Proteinuria and outcome of 444 pregnancies complicated by hypertension Am J Obstet Gynecol 162 1990 366 371
63. J.M. Ginsburg, B.S. Chang, R.A. Matarese, and S. Garella Use of single voided urine samples to estimate quantitative proteinuria N Engl J Med 309 1983 1543 1546
64. M. Robert, F. Sapandj, R.M. Liston, and K.C. Dooley Random protein-creatine ratio for the quantification of proteinuria in pregnancy Obstet Gynecol 90 1997 893 895
65. D. Rodriguez-Thompson, and E.S. Lieberman Use of a random protein-to-creatinine ratio for the diagnosis of significant proteinuria during pregnancy Am J Obstet Gynecol 185 2001 808
66. M.C. Morris, D.M. Twickler, M.R. Hatab, G.O. Clark, R.M. Peshock, and F.G. Cunningham Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia Obstet Gynecol 89 1997 561 568
67. American College of Obstetricians and Gynecologists Diagnosis and management of preeclampsia and eclampsia. ACOG practice bulletin #33 2002 American College of Obstetricians and Gynecologists Washington (DC)
68. American College of Obstetricians and Gynecologists Chronic hypertension in pregnancy. ACOG technical bulletin #29 2001 American College of Obstetricians and Gynecologists Washington (DC)
69. L.A. Magee, B. Schick, A.E. Donnenfeld, S.R. Sage, B. Conover, and L. Cook The safety of calcium channel blockers in human pregnancy: a prospective multicenter cohort study Am J Obstet Gynecol 174 1996 823 828
70. P. von Dadelszen, M.P. Ornstein, S.B. Bull, A.G. Logan, G. Koren, and L.A. Magee Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis Lancet 355 2000 87 92
71. A.G. Witlin, and B.M. Sibai Magnesium sulfate therapy in preeclampsia and eclampsia Obstet Gynecol 92 1998 883 889
72. M.J. Lucas, K.J. Leveno, and F.G. Cunningham A comparison of magnesium sulfate and phenytoin for the prevention of eclampsia N Engl J Med 333 1995 201 204
73. Do women with preeclampsia and their babies, benefit from magnesium sulfate? The Magpie trial: a randomized placebo controlled trial Lancet 359 2002 1877 1890
74. L.S. Polley Anesthetic management of hypertension in pregnancy Clin Obstet Gynecol 46 2003 688 699
75. Working group report on high blood pressure in pregnancy 2000 National Institutes of Health Washington (DC)
76. J. Alexander, R.E. Cueller, and D.H. van Thiel Toxemia of pregnancy and the liver Semin Liver Dis 7 1987 55 58
77. B.M. Sibai The HELLP syndrome (hemolysis, elevated liver enzymes and low platlets): much ado about nothing? Am J Obstet Gynecol 162 1990 311 316
78. M. Yu, A. Nardella, and L. Pechet Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnosis Crit Care Med 28 2000 1777 1780
79. M.C. Mabie, and B.M. Sibai Transient diabetes insipidus in a patient with preeclampsia and HELLP syndrome R.C. Cefalo Clinical decisions in obstetrics and gynecology 1990 Aspen Rockville (MD) 136 138
80. J.R. Martin Jr, K.G. Perry Jr, and P.G. Blake Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome Am J Obstet Gynecol 177 1997 1011 1016
81. C.M. Isler, P.S. Barrilleaux, E.F. Magnann, J.O. Bass, and J.N. Martin Jr A prospective randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome Am J Obstet Gynecol 184 2001 1332 1337
82. J.N. Martin Jr, B.D. Thigpen, C.H. Rose, and J. Cushman Maternal benefit of high dose intravenous corticosteroid therapy for HELLP syndrome Am J Obstet Gynecol 189 2003 830 834
83. F.F. Magann, D. Bass, and S.P. Chauhan Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes and low platlets (HELLP) Am J Obstet Gynecol 171 1994 1148 1153
84. C.A. Sullivan, E.F. Magann, and K.G. Perry Jr The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platlets (HELLP) in subsequent gestations Am J Obstet Gynecol 171 1994 940 943